desmoid tumor research l-carnitine A Metabolomics Pilot Study on Tumors and Novel Drug Candidates First FDA-approved Treatment for Desmoid
First FDA approved Treatment for Desmoid Tumors AACR Our Strategy & Impact The Desmoid Tumor Research Foundation L carnitine ameliorates the muscle wasting of cancer cachexia through the AKT FOXO3a MaFbx axis Nutrition & Metabolism Springer Nature Link Frontiers L carnitine prevents lenvatinib induced muscle toxicity without impairment of the anti angiogenic efficacy
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



